INCOME TAX (Details Narrative) |
12 Months Ended | |||
|---|---|---|---|---|
|
Mar. 31, 2018
HKD ($)
|
Sep. 30, 2025
USD ($)
|
Sep. 30, 2025
HKD ($)
|
Sep. 30, 2024
HKD ($)
|
|
| Operating Loss Carryforwards [Line Items] | ||||
| Assessing profits of qualifying entity | $ 2,000,000 | |||
| Tax Rate for 2 million of assessable profits of qualifying entity | 8.25% | |||
| Tax Rate for remaining assessable profits of qualifying entity | 16.50% | |||
| Assessable profits chargeable tax rate | 16.50% | |||
| Provision for allowance for credit loss | $ 1,519,650 | $ 1,126,455 | ||
| Lease liabilities | 896,536 | 770,659 | ||
| Net Income Losses | $ (2,374,981) | $ (18,484,477) | $ 10,653,488 | |
| Tax Authority Term | 10 years | 10 years | 10 years | |
| Tax Authority [Member] | ||||
| Operating Loss Carryforwards [Line Items] | ||||
| Tax Authority Term | 6 years | 6 years | 6 years | |
| HONG KONG | ||||
| Operating Loss Carryforwards [Line Items] | ||||
| Assessing profits of qualifying entity | $ 2,000,000 | |||
| X | ||||||||||
- Definition The element represents deferred tax assets lease liabilities. No definition available.
|
| X | ||||||||||
- Definition The element represents effective income tax rate reconciliation remaining assessable profits. No definition available.
|
| X | ||||||||||
- Definition The element represents net income losses. No definition available.
|
| X | ||||||||||
- Definition The element represents tax authority term. No definition available.
|
| X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in foreign income tax contingency. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|